Form D · Biotechnology
Numerion Labs, Inc.
San Francisco, CA · CIK 0001736153
Offering snapshot reported Mar 19, 2026 · SEC filing
- Reported sold
- $19.8M Offering amount: $35M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2026 | Initial | $19,794,945 | No comparison | 5 | SEC filing |
| Mar 14, 2025 | Initial | $44,282,650 | No comparison | 19 | SEC filing |
| Aug 11, 2020 | Initial | $123,010,086 | No comparison | 25 | SEC filing |
| Jul 2, 2018 | Initial | $51,492,758 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-577049
Offer and sale of Series D Preferred Stock and Common Stock issuable upon conversion thereof. Certain outstanding shares of Common Stock were exchanged for shares of a specific series of Issuer's Preferred Stock for no consideration.
Source: Form D, filed Mar 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Raj Ganguly | Director |
| Abraham Heifets | Director, Executive |
| Han Lim | Executive |
| Linda Maxwell | Director |
| Robert Mittendorff | Director |
| Matt Ocko | Director |
| Adam Seabrook | Director |
| Kiersten Stead | Director |
| Gavin Teo | Director |
| Mike Varney | Director |
| Izhar Wallach | Director |
| Stephen Worland | Director, Executive |
| Yan Zhao | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
250 Sutter St. Suite 650
San Francisco, CA, 94108
San Francisco, CA, 94108